Evidence map›Paper›PMID 27304615›Full record

ArticlePLoS pathogens2016

Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment.

Simone A Joosten, Krista E van Meijgaarden, Franca Del Nonno, Andrea Baiocchini, Linda Petrone, Valentina Vanini, Hermelijn H Smits, Fabrizio Palmieri, Delia Goletti, Tom H M Ottenhoff

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 168 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Blood transcriptomic signatures distinguishEmerging microbes & infections · 2026
    Article
  4. Article
  5. Tuberculosis treatment and cytotoxic immune signatures: a longitudinal study.Journal of clinical tuberculosis and other mycobacterial diseases · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Circulating antibody signatures againstFrontiers in immunology · 2026
    Article
  11. Host- and pathogen-related determinants of pulmonaryEuropean respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. B Cell and Antibody Responses in Bovine Tuberculosis.Antibodies (Basel, Switzerland) · 2024
    Review

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Simone A JoostenDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Krista E van MeijgaardenDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Franca Del NonnoPathology Service, National Institute for Infectious Diseases, Rome, Italy.
Andrea BaiocchiniPathology Service, National Institute for Infectious Diseases, Rome, Italy.
Linda PetroneDepartment of Epidemiology and Preclinical Research, National Institute for Infectious Diseases, Rome, Italy.
Valentina VaniniDepartment of Epidemiology and Preclinical Research, National Institute for Infectious Diseases, Rome, Italy.
Hermelijn H SmitsDepartment of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.
Fabrizio PalmieriClinical Department, National Institute for Infectious Diseases, Rome, Italy.
Delia GolettiDepartment of Epidemiology and Preclinical Research, National Institute for Infectious Diseases, Rome, Italy.
Tom H M OttenhoffDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Leiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B-cells not only produce immunoglobulins and present antigens to T-cells, but also additional key roles in the immune system. Current knowledge on the role of B-cells in infections caused by intracellular bacteria is fragmentary and contradictory. We therefore analysed the phenotypical and functional properties of B-cells during infection and disease caused by Mycobacterium tuberculosis (Mtb), the bacillus causing tuberculosis (TB), and included individuals with latent TB infection (LTBI), active TB, individuals treated successfully for TB, and healthy controls. Patients with active or treated TB disease had an increased proportion of antibodies reactive with mycobacteria. Patients with active TB had reduced circulating B-cell frequencies, whereas only minor increases in B-cells were detected in the lungs of individuals deceased from TB. Both active TB patients and individuals with LTBI had increased relative fractions of B-cells with an atypical phenotype. Importantly, these B-cells displayed impaired proliferation, immunoglobulin- and cytokine- production. These defects disappeared upon successful treatment. Moreover, T-cell activity was strongest in individuals successfully treated for TB, compared to active TB patients and LTBI subjects, and was dependent on the presence of functionally competent B-cells as shown by cellular depletion experiments. Thus, our results reveal that general B-cell function is impaired during active TB and LTBI, and that this B-cell dysfunction compromises cellular host immunity during Mtb infection. These new insights may provide novel strategies for correcting Mtb infection-induced immune dysfunction towards restored protective immunity.

Indexed as

B-LymphocytesEnzyme-Linked Immunosorbent AssayFlow CytometryHumansImmunohistochemistryLatent TuberculosisMycobacterium tuberculosisPhenotypeTuberculosis

Identifiers

PMID27304615
PMCPMC4909319
OpenAlexW2437228747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.